Seshadri Neervannan sold $363K of Tarsus Pharmaceuticals (TARS)

Executed Mar 18 2025, disclosed Mar 20 2025, 2 days later.

Value, as filed

$363K

7,583 sh across 3 lots

Executed

Mar 18 2025

the trade date, as filed

Disclosed

Mar 20 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Seshadri Neervannan Chief Operating Officer profile →

Seshadri Neervannan (Chief Operating Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $772K of TARS (11,324 sh across 3 lots, as filed), executed Mar 17.

The name

TARS

Tarsus Pharmaceuticals, Inc. TARS · Healthcare · 35 filings in 24 months ticker →

Healthcare · Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Seshadri Neervannan in TARS

TARSSALE Tarsus Pharmaceuticals, Inc. $388K
4,564 sh × $85.00
Exec Sep 4
Filed Sep 9 · 4:12 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $200K
2,989 sh × $66.75
Exec Mar 20
Filed Mar 24 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $772K
11,324 sh across 3 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $641K
8,366 sh × $76.67
Exec Mar 4
Filed Mar 5 · 5:30 PM ET